Publication of Results for quarter and year ended March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Kimia Biosciences Ltd (Scrip Code: 530313) has submitted newspaper clippings of its audited financial results for the quarter and year ended March 31, 2026 to BSE. The results were approved by the Board of Directors at a meeting held on May 29, 2026, and published in Financial Express (English) and Jansatta (Hindi) on May 31, 2026. The filing is being made under Regulation 47 of SEBI's Listing Obligations and Disclosure Requirements. This is a procedural compliance submission — the financial results themselves were already published in the newspapers on May 31, 2026. No new material figures or developments were disclosed in this particular filing beyond what was already in the public domain.
This is a routine regulatory filing with no new information for investors — the results were already published last week. Shareholders should refer to the original May 31, 2026 newspaper publications or the detailed BSE filing for actual financial numbers. No immediate stock price impact is expected from this compliance submission.